
Nicholas Peoples, MD, discusses mass surveillance enabled by artificial intelligence and its potential effects on population health. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4iQxKgJ

Executive Managing Editor @NEJM

Nicholas Peoples, MD, discusses mass surveillance enabled by artificial intelligence and its potential effects on population health. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4iQxKgJ

Irene Papanicolas, PhD, discusses the role of profit in the U.S. health insurance sector and policy lessons from other countries. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/48hnzNz

Anjali D. Deshmukh, MD, JD, discusses legal challenges to fines issued by federal agencies. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4A0kvRJ

Matthew Vogel, MBA, discusses the emergence of clinical trial prediction markets. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4ivvwnU

Lena K. Makaroun, MD, discusses opportunities for clinicians to address firearm-related risks with their older patients. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4hGwgX6

Sarah H. Schmitz, MD, discusses protections for people enrolled in trials of investigational agents for obesity. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4y1G6aM

Benjamin D. Scher, DPhil, discusses opioid litigation and governance systems for spending related funds. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4z6uqVo

Taking a look at some recent vaccine recommendations. Some hits, some misses. And a hope for better data to inform these decisions. Free to read link in replies. @NEJM @NEJMClinician

Christopher B. Forrest, MD, PhD, discusses declines in the health of U.S. children and the role of communities in reversing those trends. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4cV6xrg

Dhruv Khullar, MD, MPP, discusses concerns about displacement of clinicians by artificial intelligence and counterarguments based on economic theory. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4yHRxW8

Elizabeth Kaplan, JD, discusses changes to the USPSTF and the importance of evidence-based recommendations for preventive services. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4xQqWpG

Elizabeth Tobin-Tyler, JD, critiques the legal argument that permitting telehealth access to mifepristone can abet reproductive coercion. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4zPEiDS

Rebecca L. Haffajee, JD, PhD, MPH, discusses the rescheduling of medical marijuana products and its potential effect on research. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4gjJh6O

Eric C. Schneider, MD, discusses the limitations of pay-for-performance programs and alternative options to support quality improvement. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4hMFnpN

Jean B. Nachega, MD, PhD, MPH, discusses the importance of investment in equitable partnerships, community trust, and local scientific leadership for outbreak preparedness. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4cnjBFh

Jerry Avorn, MD, discusses the role of litigation in addressing product-related damage to health. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4hEvVV7